These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 799490)

  • 21. The effects of heparin and oral anticoagulants on thrombus propagation and prevention of the postphlebitic syndrome: a critical review of the literature.
    Egermayer P
    Prog Cardiovasc Dis; 2001; 44(1):69-80. PubMed ID: 11533928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy).
    Palareti G; Manotti C; DAngelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berrettini M; Leali N; Poggi M; Legnani C; Musolesi S; Coccheri S
    Thromb Haemost; 1997 Dec; 78(6):1438-43. PubMed ID: 9423791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient education and oral anticoagulant therapy.
    Barcellona D; Contu P; Marongiu F
    Haematologica; 2002 Oct; 87(10):1081-6. PubMed ID: 12368164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oral anticoagulation in the secondary prevention of cerebrovascular disease. Long-term follow-up of 169 patients].
    Palomeras E; Roquer J; Pou A
    Rev Neurol; 1998 Nov; 27(159):772-6. PubMed ID: 9859148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Femoral-popliteal arteriosclerosis. Medical treatment].
    Alonso T
    Angiologia; 1972; 24(5):201-5. PubMed ID: 5069570
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-term anticoagulant therapy in cardiology].
    Serradimigni A; Siccardi F; Levy G; Chabaud R
    Mars Med; 1970; 107(12):999-1004. PubMed ID: 5532434
    [No Abstract]   [Full Text] [Related]  

  • 27. A computerized regulation of dosage in oral anticoagulant therapy.
    Mariani G; Manotti C; Dettori AG
    Ric Clin Lab; 1990; 20(2):119-25. PubMed ID: 2371492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Arterial diseases of the lower limbs. Treatment with anticoagulants. Value of their long-term use].
    Jouve A; Pierron J; Avril P; Nakache A
    Nouv Presse Med; 1972 Sep; 1(34):2250-2. PubMed ID: 4628245
    [No Abstract]   [Full Text] [Related]  

  • 29. Glomerulosclerosis, arteriosclerosis, and vascular graft stenosis: treatment with oral heparinoids.
    Striker GE; Lupia E; Elliot S; Zheng F; McQuinn C; Blagg C; Selim S; Vilar J; Striker LJ
    Kidney Int Suppl; 1997 Dec; 63():S120-3. PubMed ID: 9407438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation for the long-term treatment of VTE in patients with cancer.
    Guirguis-Blake J
    Am Fam Physician; 2009 Jul; 80(1):30. PubMed ID: 19621843
    [No Abstract]   [Full Text] [Related]  

  • 31. Duration of anticoagulant therapy after initial idiopathic venous thromboembolism.
    Frazee LA; Chomo DL
    Ann Pharmacother; 2003 Oct; 37(10):1489-96. PubMed ID: 14519045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term anticoagulant treatment of arterial diseases of the legs].
    Verstraete M
    Sem Hop Ther; 1976 Apr; 52(4):221-6. PubMed ID: 821148
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term anticoagulant treatment after myocardial infarction. A review.
    de Geest H; Van De Werf F
    Brux Med; 1973 Jan; 53(1):33-5. PubMed ID: 4196294
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of a long-term anticoagulant therapy in patients with arteriosclerosis obliterans compared to a collective group with myocardial infarct].
    Schmidt HH; Heine H; Zimmermann B; Hackenberger F
    Z Gesamte Inn Med; 1971 Oct; 26(20):Suppl 20:275-7. PubMed ID: 5004145
    [No Abstract]   [Full Text] [Related]  

  • 35. [Must routine anticoagulant treatment be used in arteritis of the extremities?].
    Audier M; Galinier L
    Mars Med; 1966; 103(3):211-3. PubMed ID: 5930386
    [No Abstract]   [Full Text] [Related]  

  • 36. [Advantages of a cardiologic ambulatory care facility specifically organized for patients undergoing treatment with oral anticoagulant drugs].
    Pengo V; Peruzzi P; Marzari A; Zanon F; Banzato A; Schivazappa L
    G Ital Cardiol; 1989 Dec; 19(12):1125-8. PubMed ID: 2561357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term anticoagulant therapy in atherosclerotic peripheral arterial disease.
    Richards RL; Begg TB
    Vasc Dis; 1967 Feb; 4(1):27-35. PubMed ID: 6019430
    [No Abstract]   [Full Text] [Related]  

  • 38. A preliminary assessment of the critical differences between novel oral anticoagulants currently in development.
    McBride BF
    J Clin Pharmacol; 2005 Sep; 45(9):1004-17. PubMed ID: 16100294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is the use of anticoagulants really correct in carotid atheromatous pathology?].
    Pizzetti F
    Recenti Prog Med; 1988 Sep; 79(9):361-4. PubMed ID: 3201031
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of long-term dispensary anticoagulant therapy in patients with myocardial infarct and peripheral arteriosclerosis].
    Heine H; Schmidt H; Jahn E; Kornotzki M
    Z Gesamte Inn Med; 1973 Jan; 28(2):27-30. PubMed ID: 4632545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.